A reverse combination of structure-based and ligand-based strategies for virtual screening

被引:0
|
作者
Álvaro Cortés-Cabrera
Federico Gago
Antonio Morreale
机构
[1] Universidad de Alcalá,Departamento de Farmacología
[2] Centro de Biología Molecular Severo Ochoa (CSIC/UAM),Unidad de Bioinformática
关键词
Fragment screening; Structure-based virtual screening; Ligand-based virtual screening; Docking; Drug design;
D O I
暂无
中图分类号
学科分类号
摘要
A new approach is presented that combines structure- and ligand-based virtual screening in a reverse way. Opposite to the majority of the methods, a docking protocol is first employed to prioritize small ligands (“fragments”) that are subsequently used as queries to search for similar larger ligands in a database. For a given chemical library, a three-step strategy is followed consisting of (1) contraction into a representative, non-redundant, set of fragments, (2) selection of the three best-scoring fragments docking into a given macromolecular target site, and (3) expansion of the fragments’ structures back into ligands by using them as queries to search the library by means of fingerprint descriptions and similarity criteria. We tested the performance of this approach on a collection of fragments and ligands found in the ZINC database and the directory of useful decoys, and compared the results with those obtained using a standard docking protocol. The new method provided better overall results and was several times faster. We also studied the chemical diversity that both methods cover using an in-house compound library and concluded that the novel approach performs similarly but at a much smaller computational cost.
引用
收藏
页码:319 / 327
页数:8
相关论文
共 50 条
  • [21] Discovering new PI3Kα inhibitors with a strategy of combining ligand-based and structure-based virtual screening
    Yu, Miao
    Gu, Qiong
    Xu, Jun
    [J]. JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 2018, 32 (02) : 347 - 361
  • [22] Combination of ligand-based and structure-based virtual screening for the discovery of novel Janus kinase 2 inhibitors against philadelphia-negative myeloproliferative neoplasms
    Wang, Binyou
    Guo, Jianmin
    Chen, Bo
    Jiao, Yan
    Wan, Ying
    Wu, Jianming
    Wang, Yiwei
    [J]. MOLECULAR DIVERSITY, 2024,
  • [23] Hsp90 Inhibitors, Part 2: Combining Ligand-Based and Structure-Based Approaches for Virtual Screening Application
    Caroli, Antonia
    Ballante, Flavio
    Wickersham, Richard B., III
    Corelli, Federico
    Ragno, Rino
    [J]. JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2014, 54 (03) : 970 - 977
  • [24] Discovery of Novel Aldose Reductase Inhibitors via the Integration of Ligand-Based and Structure-Based Virtual Screening with Experimental Validation
    Yasir, Muhammad
    Park, Jinyoung
    Chun, Wanjoo
    [J]. ACS OMEGA, 2024, 9 (18): : 20338 - 20349
  • [25] Discovering new PI3Kα inhibitors with a strategy of combining ligand-based and structure-based virtual screening
    Miao Yu
    Qiong Gu
    Jun Xu
    [J]. Journal of Computer-Aided Molecular Design, 2018, 32 : 347 - 361
  • [26] Benchmarking Platform for Ligand-Based Virtual Screening
    Skoda, Petr
    Hoksza, David
    [J]. 2016 IEEE INTERNATIONAL CONFERENCE ON BIOINFORMATICS AND BIOMEDICINE (BIBM), 2016, : 1220 - 1227
  • [27] Ligand-based structural hypotheses for virtual screening
    Jain, AN
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (04) : 947 - 961
  • [28] HELIOS, A LIGAND-BASED VIRTUAL SCREENING SOLUTION
    Villacanas, Oscar
    Diaz, Joan
    Maresma, Xavier
    Grau, Raimon
    Huertas, Oscar
    Belda, Ignasi
    [J]. DRUGS OF THE FUTURE, 2009, 34 : 116 - 116
  • [29] New methodologies for ligand-based virtual screening
    Stahura, FL
    Bajorath, M
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2005, 11 (09) : 1189 - 1202
  • [30] Platform for ligand-based virtual screening integration
    Skoda, Petr
    Hoksza, David
    Jelinek, Jan
    [J]. 2017 IEEE INTERNATIONAL CONFERENCE ON BIOINFORMATICS AND BIOMEDICINE (BIBM), 2017, : 2256 - 2259